Tag: SAGE

By Posted on Posted in Fundamental Valuation Report

Fundamental Valuation Report Vir Biotechnology(VIR:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$45.28 (USD) 05/21/2021 Weighted Valuation$47.03 (USD) Overall RatingFairly valued to slightly Undervalued by 3.9% Valuation Models Adjusted …

Vir Biotechnology (VIR:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Fundamental Valuation Report

Fundamental Valuation Report Iovance Biotherapeutics(IOVA:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$31.44 (USD) 04/30/2021 Weighted Valuation$28.57 (USD) Overall RatingOvervalued by 9.1% Valuation Models Comparables: $26.70 (USD) (in order …

Iovance Biotherapeutics (IOVA:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Fundamental Valuation Report

Fundamental Valuation Report Allogene Therapeutics(ALLO:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$32.86 (USD) 04/15/2021 Weighted Valuation$36.86 (USD) Overall RatingUndervalued by 12.2% Valuation Models Adjusted Book Value: $36.87 (USD) …

Allogene Therapeutics (ALLO:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Fundamental Valuation Report

Fundamental Valuation Report Nektar Therapeutics(NKTR:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$19.99 (USD) 03/26/2021 Weighted Valuation$24.92 (USD) Overall RatingUndervalued by 24.7% Valuation Models Comparables: $24.92 (USD) Valuation Methods …

Nektar Therapeutics (NKTR:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Fundamental Valuation Report

Fundamental Valuation Report Intellia Therapeutics(NTLA:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$64.73 (USD) 03/26/2021 Weighted Valuation$49.50 (USD) Overall RatingOvervalued by 23.5% Valuation Models Comparables: $42.66 (USD) Valuation Methods …

Intellia Therapeutics (NTLA:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Uncategorised

Fundamental Valuation Report Amarin Corp(AMRN:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$20.47 (USD) 28/02/2019 Weighted Valuation$37.42 (USD) Overall RatingUndervalued by 82.8% Valuation Models Analyst Consensus: $43.00 (USD) (in …

Amarin Corp (AMRN:NAS) Fundamental Valuation Report Read more »

Read More